Effects of nitroglycerin on erythrocyte rheology and oxygen unloading: Novel role of S-nitrosohemoglobin in relieving myocardial ischemia

Circulation

Volumn 113, Issue 21, 2006, Pages 2502-2508

  Bin, Jian Ping ^a   Doctor, Allan ^b   Lindner, Jonathan ^a   Hendersen, Edward M ^b   Le, D Elizabeth ^a   Leong Poi, Howard ^a   Fisher, Nicholas G ^a   Christiansen, Jonathan ^a   Kaul, Sanjiv ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Microspheres; Nitric oxide; Nitroglycerin; Oxygen

Indexed keywords

GLYCERYL TRINITRATE; HEMOGLOBIN DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXYGEN; S NITROSOHEMOGLOBIN; S NITROSOTHIOL; UNCLASSIFIED DRUG; HEMOGLOBIN; S-NITROSOHEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VISCOSITY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY HEMODYNAMICS; DOG; DRUG EFFECT; DRUG INFUSION; ERYTHROCYTE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; IN VITRO STUDY; MICROCIRCULATION; NONHUMAN; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; ANIMAL; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; TRANSCUTANEOUS OXYGEN MONITORING;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD GAS MONITORING, TRANSCUTANEOUS; BLOOD VISCOSITY; DOGS; ERYTHROCYTES; HEMOGLOBINS; HEMORHEOLOGY; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; NITROGLYCERIN; OXYGEN; OXYGEN CONSUMPTION;

EID: 33745128429     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.627091     Document Type: Article

References (48)

1. Marcus ML. The Coronary Circulation in Health and Disease. New York: McGraw Hill Book Company; 1983:423-426.
2. Rosenson RS. Viscosity and ischemic heart disease. J Vasc Med Biol. 1993;4:206-212.
3. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Resistance to blood flow in microvessels in vivo. Circ Res. 1994;75:904-915.
4. Pries AR, Secomb TW, Gaehtgens P, Gross JF. Blood flow in microvascular networks: experiments and simulations. Circ Res. 1990;67:826-834.
5. Vink H, Wieringa PA, Spaan JAE. Evidence that cell surface charge reduction modifies capillary red cell velocity-flux relationships in hamster cremaster muscle. J Physiol. 1995;489:193-201.
6. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK. The effects of nitric oxide on red blood cell deformability. Am J Physiol. 2003;284:H1577- H1584.
7. Kosaka H, Seiyama A. Elevation of oxygen release by nitroglycerin without an increase in blood flow in the hepatic microcirculation. Nat Med. 1997;3:456-459.
8. Singel DJ, Stamler JS. Blood traffic control. Nature. 2004;430:297.
9. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: role of nitric oxide and S-nitrosohemoglobin. Ann Rev Physiol. 2005;67:99-145.
10. McMahon TJ, Doctor A. Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc. In press.
11. Brandler M, Powell SC, Craig DM, Quick G, McMahon TJ, Goldberg RN, Stamler JS. A novel inhaled organic nitrate that affects pulmonary vascular tone in a piglet model of hypoxia-induced pulmonary hypertension. Pediatr Res. 2005;1:58:531-536.
12. Coggins MP, Le DE, Wei K, Goodman NC, Lindner JR, Kaul S. Non-invasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation. 2001;104:2471-2477.
13. Jones MN. Biological Interfaces. Amsterdam: Elsevier; 1975.
14. Sinaasappel M, Iterson MV, Ince C. Microvascular oxygen pressure in the pig intestine during haemorrhagic shock and resuscitation. J Physiol. 1999;514:245-253.
15. Sklenar J, Jayaweera AR, Kaul S. A computer-aided approach for the quantification of regional left ventricular function using two-dimensional echocardiography. J Am Soc Echocardiogr. 1992;5:33-40.
16. Doctor A, Platt R, Sheram ML, Eischeid A, McMahon T, Maxey T, Doherty J, Axelrod M, Kline J, Gurka M, Gow A, Gaston B. Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci U S A. 2005;102:5709-5714.
17. Lenormand G, Henon S, Richert A, Simeon J, Gallet F. Elasticity of the human red blood cell skeleton. Biorheology. 2003;40:247-251.
18. Suzuki Y, Tateishi N, Maeda N. Electrostatic repulsion among erythrocytes in tube flow demonstrated by the thickness of marginal cell-free layer. Biorheology. 1998;35:155-170.
19. Tsuda K, Kinoshita Y, Nishio I. Synergistic role of progesterone and nitric oxide in the regulation of membrane fluidity of erythrocytes in humans: an electron paramagnetic resonance investigation. Am J Hypertens. 2002;15:702-708.
20. Tsuda K, Kimura K, Nishio I. Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism-an electron paramagnetic resonance investigation. Biochem Res Commun. 2002;297:672-681.
21. Goel MS, Diamond SL. Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and firm polymerized from plasma. Blood. 2002;100:3797-3803.
22. Sakuma T, Leong-Poi H, Fisher NG, Goodman NC, Kaul S. Further insights into the 'no-reflow' phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr. 2003;16:15-21.
23. Kal JE, Vergroesen I, van Wezel HB. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease. Anesth Analg. 1999;88:271-278.
24. Kal JE, van Wezel HB, Porsius M, Vergroesen I, Spaan JA. Metabolic coronary flow regulation and exogenous nitric oxide in human coronary artery disease: assessment by intravenous administration of nitroglycerin. J Cardiovasc Pharmacol. 2000;35:7-15.
25. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res. 1968;22:649-659.
26. Bassenge E, Stewart DJ. Effects of nitrates in various vascular sections and regions. Z Kardiologie. 1986;75:1-7.
27. Kurz MA, Lamping KG, Bates JN, Marcus ML, Harrison DG. Mechanisms responsible for the heterogenous coronary microvascular response to nitroglycerin. Circ Res. 1991;68:847-855.
28. Sellke FW, Tomanek RJ, Harrison DG. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. J Pharmacol Exp Ther. 1991;258:365-369.
29. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2005;23:12159-12164.
30. Zhang J, Chen Z, Cobb FR, Stamler JS. Role of mitochondrial aldehyde dehydrogenase in nitroglycerin-induced vasodilation of coronary and systemic vessels: an intact canine model. Circulation. 2004;110:750-755.
31. Pawloski JR, Hess DT, Stander JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;1:409:622-626.
32. Palmer LA, Chhabra P, Doctor A, Sheram ML, Laubach VE, Gaston B. N-acetyl cysteine induces pulmonary hypertension: role of S-nitrosothiols. Proc Ann Thorac Soc. 2005;2:A708.
33. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221-226.
34. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034-2037.
35. James PE, Lang D, Tufnell-Barret T, Milsom AB, Frenneaux MP. Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res. 2004;94:976-983.
36. McMahon TJ, Ahearn GS, Moya MP, Gow AJ, Huang YC, Luchsinger BP, Nudelman R, Yan Y, Krichman AD, Bashore TM, Califf RM, Singel DJ, Piantadosi CA, Tapson VF, Stamler JS. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Nat Acad Sci U S A. 2005;102:14801-14806.
37. Pawloski JR, Hess DT, Stamler JS. Impaired vasodilation by red blood cells in sickle cell disease. Proc Nat Acad Sci U S A. 2005;102:2531-2536.
38. Datta B, Tufnell-Barrett T, Bleasdale RA, Jones CJ, Beeton I, Paul V, Frenneaux M, James P. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure. Circulation. 2004;109:1339-1342.
39. Janero DR, Bryan NS, Saijo F, Dhawan V, Schwalb DJ, Warren MC, Feelisch M. Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Nat Acad Sci U S A. 2004;10:16958-16963.
40. Chong S, Fung HL. Biochemical and pharmacological interactions between nitroglycerin and thiols: effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol. 1991;42:1433-1439.
41. Kearney MF, Brien JF, Marks GS, Lei H, Nakatsu K. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate. Drug Metab Dispos. 1998;26:547-551.
42. Sarr M, Lobysheva I, Diallo AS, Stoclet JC, Schini-Kerth VB, Muller B. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate. Eur J Pharmacol. 2005;513:119-123.
43. Sokolowska M, Bednarski M, Kwiecien I, Filipek B, Wlodek L. Bioactivation of nitroglycerin to nitric oxide (NO) and S-nitrosothiols in the rat liver and evaluation of the coexisting hypotensive effect. Fund Clin Pharmacol. 2004;18:449-456.
44. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary vessels to nitroglycerin. Am J Physiol. 1990;258:H515-H520.
45. Pawloski JR, Swaminathan RV, Stamler JS. Cell-free and erythrocytic S-nitroso-hemoglobin inhibits human platelet aggregation. Circulation. 1998;97:263-267.
46. Hebert D, Xiang JX, Lam JYT. Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance. Circulation. 1997;95:1308-1313.
47. Zampolli A, Basta G, Lazzerini G, Feelisch M, De Caterina R. Inhibition of endothelial cell activation by nitric oxide donors. J Pharmacol Exp Ther. 2000;295:818-823.
48. Kosaka H, Seiyama A. Physiological role of nitric oxide as an enhancer of oxygen transfer from erythrocytes to tissue. Biochem Res Commun. 1996;218:749-752.